A Phase IB, Double-blind, Randomized, Placebo-Controlled, Parallel Group Study of the Safety, Tolerability, Preliminary Efficacy and Pharmacodynamics of BTD-001 in Young Adults and Adolescents with Down Syndrome
Completed Phase 1 ACTRN12612000652875
Study Description
Study Details
- Registry ID:
- ACTRN12612000652875
- Conditions:
- Down syndrome
- Phase:
- Phase 1
- Target Enrollment:
- 90 participants
- Start Date:
- Age Range:
- 13–35 years
- Healthy Volunteers:
- No
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.